Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by NAIFA L BUSAIDY and HEATH SKINNER.
NAIFA L BUSAIDY
Connection Strength
0.278
HEATH SKINNER
  1. Recent advances and emerging therapies in anaplastic thyroid carcinoma. F1000Res. 2018; 7.
    View in: PubMed
    Score: 0.156
  2. Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol. 2018 Dec; 2.
    View in: PubMed
    Score: 0.042
  3. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer. 2018 07 11; 6(1):68.
    View in: PubMed
    Score: 0.040
  4. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid. 2018 07; 28(7):945-951.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.